{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:44:14Z","timestamp":1786160654191,"version":"build-2736575974"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172120"],"award-info":[{"award-number":["82172120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402570"],"award-info":[{"award-number":["82402570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFB529"],"award-info":[{"award-number":["2024AFB529"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115192","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:32:40Z","timestamp":1752607960000},"page":"115192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Role of the renin-angiotensin-aldosterone system in sepsis and its therapeutic targets"],"prefix":"10.1016","volume":"162","author":[{"given":"Xinsen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yancun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2025.115192_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.02.040","article-title":"Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: novel therapeutic implications and challenges","volume":"177","author":"Hattori","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb0015","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1097\/01.CCM.0000282072.56245.91","article-title":"Mechanisms of sepsis-induced organ dysfunction","volume":"35","author":"Abraham","year":"2007","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving Sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s13054-022-04208-5","article-title":"A Genome-Wide Association Study of Survival in Patients with sepsis","volume":"vol. 26","author":"Hernandez-Beeftink","year":"2022","journal-title":"Critical Care (London, England)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2017.0131","article-title":"Management of Sepsis and Septic Shock","volume":"317","author":"Howell","year":"2017","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2020.11946","article-title":"Effect of ascorbic acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial","volume":"324","author":"Moskowitz","year":"2020","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb0040","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1097\/CCM.0b013e31829eb98f","article-title":"Sepsis and scientific revolutions","volume":"41","author":"Artenstein","year":"2013","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728220903460332","article-title":"Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?","volume":"14","author":"Salgado","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13613-019-0600-1","article-title":"Prediction of mortality in adult patients with sepsis using six biomarkers: a systematic review and meta-analysis","volume":"9","author":"Pregernig","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.intimp.2025.115192_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105409","article-title":"Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications","volume":"167","author":"Ning","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115192_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105916","article-title":"Dysregulation of the renin-angiotensin system in septic shock: mechanistic insights and application of angiotensin II in clinical management","volume":"174","author":"Senatore","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115192_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111254","article-title":"Renin-angiotensin system and inflammation update","volume":"529","author":"Cantero-Navarro","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin Systems in the Critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit. Care Clin."},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0075","first-page":"492","article-title":"Structure and functions of angiotensinogen, hypertension research\u202f: official journal of the Japanese society of","volume":"39","author":"Lu","year":"2016","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/hr.2009.201","article-title":"Biochemical properties of renin and prorenin binding to the (pro)renin receptor","volume":"33","author":"Nabi","year":"2010","journal-title":"Hypertension research\u202f: official journal of the Japanese Society of Hypertension"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5049\/EBP.2008.6.1.42","article-title":"Renin-angiotensin system - considerations for hypertension and kidney","volume":"6","author":"Yim","year":"2008","journal-title":"Electrolyte & blood pressure\u202f: E & BP"},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12012-022-09724-y","article-title":"Unraveling the differentially articulated axes of the century-old renin-angiotensin-aldosterone system: potential therapeutic implications","volume":"22","author":"Balakumar","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-018-2210-y","article-title":"Angiotensin-(1\u20137) Attenuates Organ Injury and Mortality in Rats with Polymicrobial sepsis","volume":"vol. 22","author":"Tsai","year":"2018","journal-title":"Critical Care (London, England)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0100","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms, American journal of physiology","volume":"316","author":"Santos","year":"2019","journal-title":"Heart and circulatory physiology"},{"key":"10.1016\/j.intimp.2025.115192_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","article-title":"ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis","volume":"107","author":"Sim\u00f5es","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/cvr\/cvaa042","article-title":"Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1","volume":"117","author":"Molitor","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"14","key":"10.1016\/j.intimp.2025.115192_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/ars.2015.6498","article-title":"Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 Inflammasome via redox balance modulation","volume":"24","author":"Cai","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1\u20137): Beyond the Cardio-Renal Actions","volume":"vol. 124","author":"Passos-Silva","year":"2013","journal-title":"Clinical Sci. (London, England\u202f: 1979)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0125","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0130","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?, American journal of physiology","volume":"310","author":"Chappell","year":"2016","journal-title":"Heart and circulatory physiology"},{"key":"10.1016\/j.intimp.2025.115192_bb0135","series-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas, Proceedings of the National Academy of Sciences of the United States of America","first-page":"8258","volume":"100(14)","author":"Santos","year":"2003"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2025.115192_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171042","article-title":"Angiotensin-(1-7) improves tail skin heat loss and increases the survival of rats with polymicrobial sepsis","volume":"167","author":"Passaglia","year":"2023","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin II in Septic Shock","volume":"vol. 19","author":"Corr\u00eaa","year":"2015","journal-title":"Critical Care (London, England)"},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.115192_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.intimp.2025.115192_bb0160","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s00018-004-4246-1","article-title":"The angiotensin IV\/AT4 receptor","volume":"61","author":"Chai","year":"2004","journal-title":"Cellular and molecular life Sci.\u202f: CMLS"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0165","first-page":"411","article-title":"Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation, nature reviews","volume":"22","author":"Bekassy","year":"2022","journal-title":"Immunology"},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.115192_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115192_bb0175","doi-asserted-by":"crossref","first-page":"1704762","DOI":"10.1155\/2021\/1704762","article-title":"The level and significance of circulating angiotensin-III in patients with coronary atherosclerosis","author":"Yao","year":"2021","journal-title":"J. Renin-angiotensin-aldosterone system\u202f: JRAAS"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012644","article-title":"Angiotensin III\/AT(2) receptor\/NHE3 signaling pathway in the proximal tubules of the kidney: a novel natriuretic and antihypertensive mechanism in hypertension","volume":"8","author":"Zhuo","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0185","first-page":"2987","article-title":"Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects, FASEB journal\u202f: official publication of the Federation of American Societies for","volume":"25","author":"Jankowski","year":"2011","journal-title":"Exp. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0190","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.mnh.0000441052.44406.92","article-title":"Alamandine: a new member of the angiotensin family","volume":"23","author":"Villela","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.ATV.0000253889.09765.5f","article-title":"Mass-spectrometric identification of a novel angiotensin peptide in human plasma","volume":"27","author":"Jankowski","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0205","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/HYPERTENSIONAHA.110.161836","article-title":"Pressor and Renal Hemodynamic Effects of the Novel Angiotensin a Peptide Are Angiotensin II Type 1A Receptor Dependent","volume":"vol. 57","author":"Yang","year":"2011","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20242168","article-title":"Higher Circulating ACE2 and DPP3 but Reduced ACE and Angiotensinogen in Hyperreninemic sepsis Patients","volume":"vol. 139","author":"Chappell","year":"2025","journal-title":"Clinical Sci. (London, England\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13054-024-05120-w","article-title":"Stronger Association of Intact Angiotensinogen with Mortality than Lactate or Renin in Critical Illness: Post-hoc Analysis from the VICTAS Trial","volume":"vol. 28","author":"Chappell","year":"2024","journal-title":"Critical Care (London, England)"},{"key":"10.1016\/j.intimp.2025.115192_bb0220","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fimmu.2017.01021","article-title":"Sepsis-induced cardiomyopathy: mechanisms and treatments","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0225","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.120.318075","article-title":"Loss of hepatic angiotensinogen attenuates Sepsis-induced myocardial dysfunction","volume":"129","author":"Rong","year":"2021","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0230","doi-asserted-by":"crossref","first-page":"F245","DOI":"10.1152\/ajprenal.00477.2006","article-title":"Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2","volume":"293","author":"Gupta","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0235","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00121.2014","article-title":"Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia","volume":"311","author":"Rosa","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0240","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/cc8887","article-title":"Renin-Angiotensin System Activation Correlates with Microvascular Dysfunction in a Prospective Cohort Study of Clinical sepsis","volume":"vol. 14","author":"Doerschug","year":"2010","journal-title":"Critical Care (London, England)"},{"issue":"11","key":"10.1016\/j.intimp.2025.115192_bb0245","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00424-018-2183-3","article-title":"The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice","volume":"470","author":"Meurer","year":"2018","journal-title":"Arch. Eur. J. Physiol."},{"issue":"8\u20139","key":"10.1016\/j.intimp.2025.115192_bb0250","first-page":"1493","article-title":"Renin-angiotensin system in sepsis, clinical and experimental hypertension","volume":"9","author":"Hilgenfeldt","year":"1987","journal-title":"Part A, Theory and practice"},{"key":"10.1016\/j.intimp.2025.115192_bb0255","article-title":"Intravenous calcitriol administration regulates the renin-angiotensin system and attenuates acute lung injury in obese mice complicated with polymicrobial sepsis","volume":"141","author":"Yeh","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb0260","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00210-014-1014-0","article-title":"What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury","volume":"387","author":"Akpinar","year":"2014","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/1470320320923977","article-title":"Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice","volume":"21","author":"Bondeva","year":"2020","journal-title":"J. Renin-angiotensin-aldosterone system : JRAAS"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0270","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/rccm.202012-4461OC","article-title":"Increased angiotensin-converting enzyme 2 and loss of alveolar type II cells in COVID-19-related acute respiratory distress syndrome","volume":"204","author":"Gerard","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0275","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01188-2018","article-title":"Increase in circulating ACE-positive endothelial microparticles during acute lung injury","volume":"54","author":"Takei","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115192_bb0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2018.11.001","article-title":"BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system","volume":"140","author":"Chen","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0285","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","article-title":"Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12967-021-02755-z","article-title":"Pulmonary midkine inhibition ameliorates sepsis induced lung injury","volume":"19","author":"Xu","year":"2021","journal-title":"J. Transl. Med."},{"issue":"7047","key":"10.1016\/j.intimp.2025.115192_bb0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0300","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1213\/01.ane.0000281144.06703.0d","article-title":"Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema","volume":"105","author":"Votta-Velis","year":"2007","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0305","first-page":"287","article-title":"LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells, in vitro cellular & developmental biology","volume":"50","author":"Hermanns","year":"2014","journal-title":"Animal"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0310","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40360-022-00584-4","article-title":"Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model","volume":"23","author":"Lu","year":"2022","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jss.2013.08.004","article-title":"(pro)renin receptor blocker improves survival of rats with sepsis","volume":"186","author":"Hirano","year":"2014","journal-title":"J. Surg. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0320","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1111\/jcmm.16382","article-title":"Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106473","article-title":"Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-\u03baB and MAPK signaling","volume":"185","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0330","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/08923973.2019.1688346","article-title":"Perindopril mitigates LPS-induced cardiopulmonary oxidative and inflammatory damage via inhibition of renin angiotensin system, inflammation and oxidative stress","volume":"41","author":"El-Shoura","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury","volume":"99","author":"Leisman","year":"2021","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0340","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of Angiotensin II Type 1 Receptors during sepsis","volume":"vol. 38","author":"Bucher","year":"2001","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2009.10.006","article-title":"Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock","volume":"49","author":"Schmidt","year":"2010","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0350","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","article-title":"Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis","volume":"29","author":"Bucher","year":"2001","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0355","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc12809","article-title":"The Angiotensin II AT1 Receptor-Associated Protein Arap1 Is Involved in sepsis-Induced Hypotension","volume":"vol. 17","author":"Mederle","year":"2013","journal-title":"Critical Care (London, England)"},{"key":"10.1016\/j.intimp.2025.115192_bb0360","article-title":"Sini decoction ameliorates sepsis-induced acute lung injury via regulating ACE2-Ang (1-7)-mas axis and inhibiting the MAPK signaling pathway","volume":"115","author":"Chen","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-022-04161-3","article-title":"Myocardial Effects of Angiotensin II Compared to Norepinephrine in an Animal Model of Septic Shock","volume":"vol. 26","author":"Garcia","year":"2022","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0370","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"17","author":"Perico","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"17","key":"10.1016\/j.intimp.2025.115192_bb0375","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0380","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1753425918785008","article-title":"Lipoxin a(4) attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-mas axis","volume":"24","author":"Chen","year":"2018","journal-title":"Innate Immun."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0385","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0390","doi-asserted-by":"crossref","first-page":"27911","DOI":"10.1038\/srep27911","article-title":"Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-\u03baB signaling pathways","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0395","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2025.115192_bb0400","article-title":"Chinese yam extract and adenosine attenuated LPS-induced cardiac dysfunction by inhibiting RAS and apoptosis via the ER-mediated activation of SHC\/RAS\/Raf1 pathway","volume":"61","author":"Zeng","year":"2019","journal-title":"Phytomed.\u202f: Int. J. Phytotherapy and Phytopharmacol."},{"key":"10.1016\/j.intimp.2025.115192_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170612","article-title":"Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide","volume":"144","author":"Xu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2025.115192_bb0410","first-page":"2421198","article-title":"The pretreatment of Xiaoqinglong decoction alleviates inflammation and oxidative damage and up-regulates angiotensin-converting enzyme 2 in lipopolysaccharide-induced septic acute lung injury rats","volume":"2022","author":"Su","year":"2022","journal-title":"Evidence-based complementary and alternative medicine\u202f: eCAM"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0415","doi-asserted-by":"crossref","first-page":"F983","DOI":"10.1152\/ajprenal.00371.2010","article-title":"Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide","volume":"299","author":"Gwathmey","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6 Suppl 3","key":"10.1016\/j.intimp.2025.115192_bb0420","article-title":"Angiotensin receptors: physiology and pharmacology","volume":"18","author":"Guthrie","year":"1995","journal-title":"Clin. Cardiol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0425","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JCMA.0000000000000911","article-title":"Stimulation of angiotensin II type 2 receptor attenuates organ injury in rats with polymicrobial sepsis","volume":"86","author":"Shih","year":"2023","journal-title":"J. Chinese Med. Assoc. : JCMA"},{"key":"10.1016\/j.intimp.2025.115192_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170627","article-title":"Alamandine, a derivative of angiotensin-(1-7), alleviates sepsis-associated renal inflammation and apoptosis by inhibiting the PI3K\/Ak and MAPK pathways","volume":"146","author":"Hu","year":"2021","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0435","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","article-title":"Mechanisms and treatment of organ failure in sepsis","volume":"14","author":"Lelubre","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0440","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/SHK.0000000000001382","article-title":"Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)","volume":"53","author":"Hsieh","year":"2020","journal-title":"Shock (Augusta, Ga.)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0445","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.119.13197","article-title":"Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality after Sepsis: A Population-Based Cohort Study","volume":"vol. 75","author":"Hsu","year":"2020","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3904\/kjim.2019.262","article-title":"Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis","volume":"36","author":"Lee","year":"2021","journal-title":"Korean J. Intern. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0455","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1513\/AnnalsATS.202207-615OC","article-title":"Renin-angiotensin system inhibitors and major cardiovascular events after Sepsis","volume":"20","author":"Angriman","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0460","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2215\/CJN.05480610","article-title":"Predictors of acute kidney injury in septic shock patients: an observational cohort study","volume":"6","author":"Plataki","year":"2011","journal-title":"Clinical J. American Society of Nephrol.\u202f: CJASN"},{"key":"10.1016\/j.intimp.2025.115192_bb0465","doi-asserted-by":"crossref","first-page":"9367873","DOI":"10.1155\/2022\/9367873","article-title":"Construction and validation of a risk prediction model for acute kidney injury in patients suffering from septic shock","volume":"2022","author":"Yue","year":"2022","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0470","doi-asserted-by":"crossref","first-page":"298","DOI":"10.23736\/S0375-9393.22.16766-0","article-title":"Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock","volume":"89","author":"Baykan","year":"2023","journal-title":"Minerva Anestesiol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0475","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0480","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit. Care Med."},{"issue":"17","key":"10.1016\/j.intimp.2025.115192_bb0485","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0490","series-title":"Vasopressors for hypotensive shock, The Cochrane database of systematic reviews","volume":"2(2)","author":"Gamper","year":"2016"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0495","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00024382-199902000-00010","article-title":"Angiotensin II Receptor Antagonism Increases Gut Oxygen Delivery but Fails to Improve Intestinal Mucosal Acidosis in Porcine Endotoxin Shock","volume":"vol. 11","author":"Oldner","year":"1999","journal-title":"Shock (Augusta, Ga.)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0500","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","article-title":"The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model","volume":"48","author":"Laesser","year":"2004","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0505","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/SHK.0b013e3182115e6a","article-title":"Sublingual Microcirculatory Effects of Enalaprilat in an Ovine Model of Septic Shock","volume":"vol. 35","author":"Salgado","year":"2011","journal-title":"Shock (Augusta, Ga.)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0510","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Corr\u00eaa","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106588","article-title":"Micro-lightguide spectrophotometry assessment of hepatic and intestinal microcirculation in endotoxemic rats during intravenous treatment with angiotensin II","volume":"191","author":"Schmidt","year":"2023","journal-title":"Euro. J. Pharma. Sci. : Official J. European Federation for Pharma. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0520","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13054-023-04396-8","article-title":"Angiotensin 1\u20137 in an experimental septic shock model","volume":"27","author":"Garcia","year":"2023","journal-title":"Critical care (London, England)"},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb0530","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1097\/CCM.0000000000002729","article-title":"Evaluation of vasopressin for septic shock in patients on chronic renin-angiotensin-aldosterone system inhibitors","volume":"45","author":"Erwin","year":"2017","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0535","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SHK.0000000000001524","article-title":"Hemodynamic Impact of Cardiovascular Antihypertensive Medications in Patients with Sepsis-Related Acute Circulatory Failure","volume":"vol. 54","author":"de Roquetaillade","year":"2020","journal-title":"Shock (Augusta, Ga.)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0540","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1097\/CCM.0000000000004872","article-title":"Prior exposure to angiotensin II receptor blockers in patients with septic shock to individualize mean arterial pressure target? A post hoc analysis of the Sepsis and mean arterial pressure (SEPSISPAM) trial","volume":"49","author":"Demiselle","year":"2021","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0545","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1089253220949070","article-title":"Treatment of renin-angiotensin-aldosterone system dysfunction with angiotensin II in high-renin septic shock","volume":"25","author":"Chow","year":"2021","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0555","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous Angiotensin II for the Treatment of High-Output Shock (ATHOS Trial): A Pilot Study","volume":"vol. 18","author":"Chawla","year":"2014","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0560","first-page":"3","article-title":"6: Effect of disease severity on survival in patients receiving angiotensin ii for vasodilatory","volume":"46","author":"Szerlip","year":"2018","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb0565","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/08850666231174870","article-title":"Trajectory of PaO(2)\/FiO(2) ratio in shock after angiotensin II","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J. Intensive Care Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0570","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000978","article-title":"Utilization of synthetic human angiotensin II for catecholamine-resistant vasodilatory shock in critically ill children: a single-center retrospective case series","volume":"5","author":"Tezel","year":"2023","journal-title":"Critical care explorations"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0575","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating Angiotensin II at Lower Vasopressor Doses in Vasodilatory Shock: An Exploratory Post-hoc Analysis of the ATHOS-3 Clinical Trial","volume":"vol. 27","author":"Wieruszewski","year":"2023","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0580","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0585","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40256-018-0297-9","article-title":"FDA approval of angiotensin II for the treatment of hypotension in adults with distributive shock","volume":"19","author":"Senatore","year":"2019","journal-title":"Ame. J. Cardiovas. drugs\u202f: drugs, devices, and other interventions"},{"key":"10.1016\/j.intimp.2025.115192_bb0590","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.02.028","article-title":"PICK1 deficiency exacerbates sepsis-associated acute lung injury and impairs glutathione synthesis via reduction of xCT","volume":"118","author":"Qian","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0595","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0600","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.107.130609","article-title":"Treatment of sepsis-induced acquired protein C deficiency reverses angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response","volume":"325","author":"Richardson","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0605","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/febs.16696","article-title":"Sacubitril\/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice","volume":"290","author":"Wang","year":"2023","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0610","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SHK.0b013e318189017a","article-title":"Losartan Prevents sepsis-Induced Acute Lung Injury and Decreases Activation of Nuclear Factor kappaB and Mitogen-Activated Protein Kinases","volume":"vol. 31","author":"Shen","year":"2009","journal-title":"Shock (Augusta, Ga.)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0615","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.102.037382","article-title":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome","volume":"303","author":"Raiden","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2025.115192_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117051","article-title":"The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation","volume":"241","author":"Kostakoglu","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0625","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/CCM.0b013e3181958d91","article-title":"Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models","volume":"37","author":"Hagiwara","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0630","article-title":"Potential therapeutic implications of calcitriol administration and weight reduction on CD4 T cell dysregulation and renin angiotensin system-associated acute lung injury in septic obese mice","volume":"165","author":"Yeh","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0635","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0640","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.chest.2020.09.274","article-title":"Right ventricular dysfunction in early Sepsis and septic shock","volume":"159","author":"Lanspa","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2025.115192_bb0645","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J. Intensive Care"},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0650","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0655","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0660","first-page":"116","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease, nature reviews","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Cardiology"},{"key":"10.1016\/j.intimp.2025.115192_bb0665","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2016.06.042","article-title":"The protective role of neuregulin-1: a potential therapy for sepsis-induced cardiomyopathy","volume":"788","author":"Zhou","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0670","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-022-03842-5","article-title":"Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-\u03baB and MAPK pathways","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0675","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/atm-22-6016","article-title":"Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin 1-7","volume":"11","author":"Wu","year":"2023","journal-title":"Annals of translational medicine"},{"key":"10.1016\/j.intimp.2025.115192_bb0680","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lfs.2018.04.010","article-title":"Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways","volume":"206","author":"Li","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.115192_bb0685","article-title":"Sepsis associated acute kidney injury","volume":"364","author":"Poston","year":"2019","journal-title":"BMJ (Clinical research ed.)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0690","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0695","doi-asserted-by":"crossref","first-page":"R629","DOI":"10.1152\/ajpregu.2000.279.2.R629","article-title":"Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole, American journal of physiology","volume":"279","author":"Denton","year":"2000","journal-title":"Regulatory, integrative and comparative physiology"},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb0700","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMra064398","article-title":"Normotensive ischemic acute renal failure","volume":"357","author":"Abuelo","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0705","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in Experimental Hyperdynamic sepsis","volume":"vol. 13","author":"Wan","year":"2009","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0710","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","article-title":"Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin II therapy in septic acute kidney injury","volume":"46","author":"Lankadeva","year":"2018","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0715","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/fcp.12718","article-title":"Angiotensin aldosterone inhibitors improve survival and ameliorate kidney injury induced by sepsis through suppression of inflammation and apoptosis","volume":"36","author":"Al-Kadi","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0720","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10753-020-01316-8","article-title":"The protective effects of perindopril against acute kidney damage caused by septic shock","volume":"44","author":"Kostakoglu","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.115192_bb0725","article-title":"Angiotensin (1-7) attenuates Sepsis-induced acute kidney injury by regulating the NF-\u03baB pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0730","doi-asserted-by":"crossref","first-page":"203","DOI":"10.25122\/jml-2022-0299","article-title":"Investigating the renoprotective effect of C21 in male mice with sepsis via modulation of p-AKT\/PI3K expression","volume":"16","author":"Jabber","year":"2023","journal-title":"J. Med. Life"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0735","doi-asserted-by":"crossref","first-page":"G968","DOI":"10.1152\/ajpgi.2001.280.5.G968","article-title":"Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats, American journal of physiology","volume":"280","author":"Weiss","year":"2001","journal-title":"Gastrointestinal and liver Phys."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0740","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0745","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/08830185.2014.889129","article-title":"The role of the liver in sepsis","volume":"33","author":"Yan","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115192_bb0750","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/01.CCM.0000284492.30800.00","article-title":"Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China","volume":"35","author":"Cheng","year":"2007","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0755","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s13054-020-03327-1","article-title":"Gut-Liver Crosstalk in sepsis-Induced Liver Injury","volume":"vol. 24","author":"Sun","year":"2020","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0760","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41598-020-79902-x","article-title":"Angiotensin-(1-7) treatment blocks lipopolysaccharide-induced organ damage, platelet dysfunction, and IL-6 and nitric oxide production in rats","volume":"11","author":"Tsai","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0765","first-page":"5492","article-title":"Angiotensin-(1-7) prevents lipopolysaccharide-induced hepatocellular inflammatory response by inhibiting the p38MAPK\/AP-1 signaling pathway","volume":"17","author":"Xiao","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0770","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1089253219877876","article-title":"Angiotensin II in decompensated cirrhosis complicated by septic shock","volume":"24","author":"Coleman","year":"2020","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"issue":"16","key":"10.1016\/j.intimp.2025.115192_bb0775","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0780","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/CCM.0000000000004897","article-title":"Trajectory of cognitive decline after Sepsis","volume":"49","author":"Wang","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115192_bb0785","doi-asserted-by":"crossref","first-page":"1328729","DOI":"10.1155\/2022\/1328729","article-title":"Sepsis-induced brain dysfunction: pathogenesis","volume":"2022","author":"Pan","year":"2022","journal-title":"Diagnosis, and Treatment, Oxidative medicine and cellular longevity"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0790","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41577-021-00643-7","article-title":"Cerebral dysfunctions caused by sepsis during ageing","volume":"22","author":"Manabe","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb0795","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.imbio.2015.07.013","article-title":"Mas receptor deficiency exacerbates lipopolysaccharide-induced cerebral and systemic inflammation in mice","volume":"220","author":"Oliveira-Lima","year":"2015","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0800","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010105","article-title":"Central Administration of Angiotensin-(1-7) improves vasopressin impairment and hypotensive response in experimental Endotoxemia","volume":"10","author":"Passaglia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115192_bb0805","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2020.04.059","article-title":"Central angiotensin-(1-7) attenuates systemic inflammation via activation of sympathetic signaling in endotoxemic rats","volume":"88","author":"Passaglia","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0810","first-page":"C834","article-title":"The molecular basis of skeletal muscle atrophy","volume":"287","author":"Jackman","year":"2004","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0815","first-page":"99","article-title":"Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways, FASEB journal\u202f: official publication of the Federation of American Societies for","volume":"25","author":"Doyle","year":"2011","journal-title":"Exp. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0820","first-page":"E501","article-title":"Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle, American journal of physiology","volume":"292","author":"Frost","year":"2007","journal-title":"Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0825","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1582-4934.2011.01354.x","article-title":"Angiotensin II receptor type 1 blockade decreases CTGF\/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles","volume":"16","author":"Cabello-Verrugio","year":"2012","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0830","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00424-014-1617-9","article-title":"The angiotensin-(1-7)\/mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice","volume":"467","author":"Meneses","year":"2015","journal-title":"Arch. Eur. J. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0835","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20140215","article-title":"Angiotensin-(1\u20137) Decreases Skeletal Muscle Atrophy Induced by Angiotensin II through a Mas Receptor-Dependent Mechanism","volume":"vol. 128","author":"Cisternas","year":"2015","journal-title":"Clinical Sci. (London, England\u202f: 1979)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0840","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20140840","article-title":"Endotoxin-Induced Skeletal Muscle Wasting Is Prevented by Angiotensin-(1\u20137) through a p38 MAPK-Dependent Mechanism","volume":"vol. 129","author":"Morales","year":"2015","journal-title":"Clinical Sci. (London, England\u202f: 1979)"},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb0845","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cid\/ciab688","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections","volume":"74","author":"Baker","year":"2022","journal-title":"Clinical infectious diseases\u202f: an official publication of the infectious diseases society of America"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0850","doi-asserted-by":"crossref","DOI":"10.1186\/cc12896","article-title":"Characteristics and Outcomes of Culture-Negative Versus Culture-Positive Severe sepsis","volume":"vol. 17","author":"Phua","year":"2013","journal-title":"Critical Care (London, England)"},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb0855","first-page":"1767","article-title":"Respiratory viral infections are underdiagnosed in patients with suspected sepsis, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical","volume":"36","author":"Ljungstr\u00f6m","year":"2017","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb0860","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus disease 2019 as cause of viral Sepsis: a systematic review and Meta-analysis","volume":"49","author":"Karakike","year":"2021","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb0865","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/SHK.0000000000001769","article-title":"Cytokine Drizzle-The Rationale for Abandoning \"Cytokine Storm\"","volume":"56","author":"Stolarski","year":"2021","journal-title":"Shock (Augusta, Ga.)"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0870","volume":"18","author":"Batra","year":"2022","journal-title":"Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS"},{"key":"10.1016\/j.intimp.2025.115192_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104355","article-title":"How sepsis parallels and differs from COVID-19","volume":"86","author":"Herminghaus","year":"2022","journal-title":"EBioMedicine"},{"issue":"10224","key":"10.1016\/j.intimp.2025.115192_bb0880","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb0885","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0890","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"14","key":"10.1016\/j.intimp.2025.115192_bb0895","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.2023.3546","article-title":"Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor-biased ligand in adults with COVID-19: two randomized clinical trials","volume":"329","author":"Self","year":"2023","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0900","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jch.14101","article-title":"Hypertension, medications, and risk of severe COVID-19: a Massachusetts community-based observational study","volume":"23","author":"Bauer","year":"2021","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"14","key":"10.1016\/j.intimp.2025.115192_bb0905","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.2023.4480","article-title":"Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19: a randomized clinical trial","volume":"329","author":"Lawler","year":"2023","journal-title":"Jama"},{"issue":"25","key":"10.1016\/j.intimp.2025.115192_bb0910","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0915","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin System Inhibitors with Severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan","volume":"5","author":"Li","year":"2020","journal-title":"China, JAMA Cardiol."},{"issue":"25","key":"10.1016\/j.intimp.2025.115192_bb0920","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235248","article-title":"Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens","volume":"15","author":"Bravi","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb0930","doi-asserted-by":"crossref","first-page":"430","DOI":"10.21037\/atm.2020.03.229","article-title":"The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension","volume":"8","author":"Huang","year":"2020","journal-title":"Annals of translational medicine"},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb0935","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jinf.2020.05.056","article-title":"COVID-19 is more severe in patients with hypertension: ACEI\/ARB treatment does not influence clinical severity and outcome","volume":"81","author":"Hu","year":"2020","journal-title":"J. Infection"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19373","article-title":"Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients","volume":"9","author":"Mekary","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0945","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40265-021-01639-2","article-title":"Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use associated with reduced mortality and other disease outcomes in US veterans with COVID-19","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.intimp.2025.115192_bb0950","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13582","article-title":"COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 registry (Italy-Spain-Germany)","volume":"51","author":"El-Battrawy","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb0955","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1053\/j.gastro.2020.05.034","article-title":"Associations between angiotensin-converting enzyme inhibitors and angiotensin II receptor blocker use, gastrointestinal symptoms, and mortality among patients with COVID-19","volume":"159","author":"Tan","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2025.115192_bb0960","first-page":"249","article-title":"Correlative association of oxygenation and sepsis panels with the use of ace2 inhibitors and without it in the conditions of septic shock in covid-19-infected and non-infected patients (cohort study)","volume":"340\u2013341","author":"Rurua","year":"2023","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.intimp.2025.115192_bb0965","first-page":"110","article-title":"Impact of the angiotensin-converting enzyme (ace) inhibitors on the course of the septic shock developed during covid-19 and other severe respiratory infections in presence of hyperferritinemia","volume":"337","author":"Rurua","year":"2023","journal-title":"Georgian Med. News"},{"issue":"18","key":"10.1016\/j.intimp.2025.115192_bb0970","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115192_bb0975","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb0980","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb0985","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1053\/j.jvca.2022.07.022","article-title":"Angiotensin II - a brief review and role in severe SARS-COV-2 Sepsis","volume":"36","author":"Car\u00e0","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.intimp.2025.115192_bb0990","series-title":"Resuscitation, Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients","first-page":"215","volume":"23(2)","author":"Zangrillo","year":"2021"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb0995","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13054-020-02928-0","article-title":"Angiotensin II Infusion in COVID-19-Associated Vasodilatory Shock: A Case Series","volume":"vol. 24","author":"Zangrillo","year":"2020","journal-title":"Critical Care (London, England)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb1000","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.chest.2019.08.2182","article-title":"Mitochondria and critical illness","volume":"157","author":"Supinski","year":"2020","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.intimp.2025.115192_bb1005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of Sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10 Pt B","key":"10.1016\/j.intimp.2025.115192_bb1010","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.bbadis.2017.01.013","article-title":"Microbial recognition and danger signals in sepsis and trauma, Biochimica et biophysica acta","volume":"1863","author":"Raymond","year":"2017","journal-title":"Molecular basis of disease"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41392-021-00816-9","article-title":"Signaling pathways and intervention therapies in sepsis","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115192_bb1025","doi-asserted-by":"crossref","first-page":"8326749","DOI":"10.1155\/2017\/8326749","article-title":"PPAR-\u03b3 activation prevents septic cardiac dysfunction via inhibition of apoptosis and necroptosis","volume":"2017","author":"Peng","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2025.115192_bb1030","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/JIR.S307801","article-title":"The ACE2-Ang-(1-7)-mas Axis modulates M1\/M2 macrophage polarization to relieve CLP-induced inflammation via TLR4-mediated NF-\u043ab and MAPK pathways","volume":"14","author":"Pan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.115192_bb1035","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1038\/srep08209","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK\/NF-\u03baB pathways","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"issue":"7950","key":"10.1016\/j.intimp.2025.115192_bb1040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1045","first-page":"7867","article-title":"Effects of angiotensin II type 1 receptor antagonist on rats with septic shock","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb1050","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23080","article-title":"The cardioprotective effects of perindopril in a model of polymicrobial sepsis: the role of radical oxygen species and the inflammation pathway","volume":"36","author":"Topcu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.intimp.2025.115192_bb1055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jss.2022.05.034","article-title":"Olmesartan ameliorates organ injury and mortality in rats with peritonitis-induced Sepsis","volume":"279","author":"Tsai","year":"2022","journal-title":"J. Surg. Res."},{"issue":"8990","key":"10.1016\/j.intimp.2025.115192_bb1060","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(95)91933-3","article-title":"Severe Septic Shock Unresponsive to Noradrenaline","volume":"vol. 346","author":"Wray","year":"1995","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1213\/ANE.0000000000004343","article-title":"Reversal of vasodilatory shock: current perspectives on conventional, rescue, and emerging vasoactive agents for the treatment of shock","volume":"130","author":"Chow","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.intimp.2025.115192_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171201","article-title":"Dysfunction of the renin-angiotensin-aldosterone system in human septic shock","volume":"176","author":"Schaich","year":"2024","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1075","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock","volume":"202","author":"Bellomo","year":"2020","journal-title":"A Clinical Trial, American J. Resp. and critical care Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115192_bb1080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","article-title":"Association of Active Renin Content with Mortality in critically ill patients: a post hoc analysis of the vitamin C, thiamine, and steroids in Sepsis (VICTAS) trial","volume":"52","author":"Busse","year":"2024","journal-title":"Crit. Care Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115192_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients: a prospective observational study","volume":"23","author":"Le\u015bnik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1090","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1038\/s41598-024-56994-3","article-title":"Plasma renin as a novel prognostic biomarker of sepsis-associated acute respiratory distress syndrome","volume":"14","author":"Chakradhar","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb1095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4266\/kjccm.2017.00094","article-title":"Implications of plasma renin activity and plasma aldosterone concentration in critically ill patients with septic shock","volume":"32","author":"Chung","year":"2017","journal-title":"Korean J. Critical care Med."},{"issue":"10","key":"10.1016\/j.intimp.2025.115192_bb1100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199810000-00018","article-title":"Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill","volume":"26","author":"Boldt","year":"1998","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.shk.0000054369.40802.35","article-title":"Enalapril Does Not Alter Adhesion Molecule Levels in Human Endotoxemia","volume":"vol. 19","author":"Graninger","year":"2003","journal-title":"Shock (Augusta, Ga.)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1110","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bcp.12419","article-title":"Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis","volume":"78","author":"Dial","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115192_bb1115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022870","article-title":"Effects of renin-angiotensin-aldosterone system inhibitors on long-term major adverse cardiovascular events in Sepsis survivors","volume":"10","author":"Ou","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb1120","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1592\/phco.27.12.1619","article-title":"Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis","volume":"27","author":"Mortensen","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1125","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2025.115192_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.153986","article-title":"RAS inhibition and sepsis-associated acute kidney injury","volume":"69","author":"Flannery","year":"2022","journal-title":"J. Crit. Care"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb1135","first-page":"293","article-title":"Angiotensin converting enzyme (ACE) insertion\/deletion (I\/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients","volume":"50","author":"Tsantes","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb1140","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.23736\/S0375-9393.22.16566-1","article-title":"Angiotensin II and angiotensin II receptor 2 levels can predict shock and mortality in septic patients","volume":"88","author":"Ozer","year":"2022","journal-title":"Minerva Anestesiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1145","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/CCM.0000000000003475","article-title":"Risk of Sepsis and mortality among patients with chronic obstructive pulmonary disease treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"47","author":"Lai","year":"2019","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb1150","first-page":"e15","article-title":"Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High among Intensive Care Unit Patients with Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death","volume":"vol. 75","author":"Sunden-Cullberg","year":"2020","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1155","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1097\/CCM.0000000000003654","article-title":"Effect of antihypertensive medications on Sepsis-related outcomes: a population-based cohort study","volume":"47","author":"Kim","year":"2019","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1160","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1515\/CCLM.2011.626","article-title":"Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia","volume":"49","author":"Meijvis","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb1165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3349\/ymj.2013.54.4.965","article-title":"Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes","volume":"54","author":"Suh","year":"2013","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1060028017726552","article-title":"Effects of chronic Antihypertensives on vasopressor dosing in septic shock","volume":"52","author":"DeMott","year":"2018","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb1175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.23736\/S0375-9393.22.16766-0","article-title":"Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock","volume":"89","author":"Baykan","year":"2023","journal-title":"Minerva Anestesiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1180","first-page":"21","article-title":"Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury","volume":"41","author":"Suberviola","year":"2017","journal-title":"Med. Int."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1185","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s00467-023-05930-0","article-title":"Serum Renin and Prorenin Concentrations Predict Severe Persistent Acute Kidney Injury and Mortality in Pediatric Septic Shock","volume":"vol. 38","author":"Stanski","year":"2023","journal-title":"Pediat. Nephrol. (Berlin, Germany)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-023-04518-2","article-title":"Increasing Angiotensin-Converting Enzyme Concentrations and Absent Angiotensin-Converting Enzyme Activity Are Associated with Adverse Kidney Outcomes in Pediatric Septic Shock","volume":"vol. 27","author":"Pode-Shakked","year":"2023","journal-title":"Critical Care (London, England)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb1195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CDLI.7.4.635-640.2000","article-title":"Angiotensin II increases host resistance to peritonitis","volume":"7","author":"Rodgers","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.intimp.2025.115192_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173953","article-title":"Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock","volume":"897","author":"Fernandes","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"34","key":"10.1016\/j.intimp.2025.115192_bb1205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211370119","article-title":"Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model","volume":"119","author":"Leisman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1210","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1097\/CCM.0000000000003296","article-title":"MicroRNA-155 amplifies nitric oxide\/cGMP signaling and impairs vascular angiotensin II reactivity in septic shock","volume":"46","author":"Vasques-N\u00f3voa","year":"2018","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb1215","first-page":"1943","article-title":"Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats","volume":"106","author":"Shimizu","year":"2009","journal-title":"J. Appl. Physiol. (Bethesda, Md.\u202f: 1985)"},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1220","first-page":"1205","article-title":"Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis, Brazilian journal of medical and biological research =","volume":"39","author":"Rahal","year":"2006","journal-title":"Revista brasileira de pesquisas medicas e biologicas"},{"issue":"2","key":"10.1016\/j.intimp.2025.115192_bb1225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/03009739909178959","article-title":"An inhibitor of angiotensin converting enzyme (enalapril) augments endotoxin-induced hypotension in the pig","volume":"104","author":"Kiiski","year":"1999","journal-title":"Ups. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115192_bb1230","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00134-004-2198-4","article-title":"Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock","volume":"30","author":"Wiel","year":"2004","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.0000077984.85616.23","article-title":"Downregulation of Angiotensin Subtype 1 Receptor in Rostral Ventrolateral Medulla during Endotoxemia","volume":"vol. 42","author":"Chan","year":"2003","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb1240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SHK.0000000000000115","article-title":"Receptor MAS Protects Mice against Hypothermia and Mortality Induced by Endotoxemia","volume":"vol. 41","author":"Souza","year":"2014","journal-title":"Shock (Augusta, Ga.)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb1245","doi-asserted-by":"crossref","first-page":"H3726","DOI":"10.1152\/ajpheart.01116.2007","article-title":"Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice, American journal of physiology","volume":"293","author":"Lund","year":"2007","journal-title":"Heart and circulatory physiology"},{"issue":"7","key":"10.1016\/j.intimp.2025.115192_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270920","article-title":"ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury","volume":"17","author":"Minato","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115192_bb1255","article-title":"Possible contribution of the neprilysin\/ACE pathway to sepsis in mice","volume":"258","author":"Ugan","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.115192_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115192_bb1265","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/CCM.0000000000005589","article-title":"Renin-angiotensin system pathway therapeutics associated with improved outcomes in males hospitalized with COVID-19","volume":"50","author":"Rocheleau","year":"2022","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115192_bb1270","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00220-22","article-title":"Repressed Ang 1-7 in COVID-19 is inversely associated with inflammation and coagulation","volume":"7","author":"Carpenter","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.intimp.2025.115192_bb1275","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221122544","article-title":"The prognostic importance of the angiotensin II\/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infection","volume":"16","author":"Amezcua-Guerra","year":"2022","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115192_bb1280","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2025.115192_bb1285","series-title":"Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients with COVID-19 and Hypertension: A Single-Center Retrospective Study, Hypertension (Dallas, Tex.\u202f: 1979)","first-page":"51","article-title":"Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme)","volume":"vol. 76(1)","author":"Yang","year":"2020"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1290","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerging microbes & infections"},{"issue":"6","key":"10.1016\/j.intimp.2025.115192_bb1295","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust","volume":"22","author":"Bean","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"20","key":"10.1016\/j.intimp.2025.115192_bb1300","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.intimp.2025.115192_bb1305","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jmv.27592","article-title":"Angiotensin II infusion in COVID-19: An international, multicenter, registry-based study","volume":"94","author":"Serpa Neto","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2025.115192_bb1310","series-title":"Resuscitation, Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: A case series","first-page":"388","volume":"22(4)","author":"Morselli","year":"2020"},{"issue":"1","key":"10.1016\/j.intimp.2025.115192_bb1315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s13054-020-03143-7","article-title":"Angiotensin II Treatment in COVID-19 Patients: More Risk than Benefit? A Single-Center Experience","volume":"vol. 24","author":"Heinicke","year":"2020","journal-title":"Critical Care (London, England)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:34:53Z","timestamp":1786160093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":263,"alternative-id":["S1567576925011828"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115192","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the renin-angiotensin-aldosterone system in sepsis and its therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115192"}}